$ASND
Ascendis Pharma A/S Ordinary Share
XNAS•Health Care•Pharmaceutical Preparations
$227.30
▲+0.13%+$0.300
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAscendis Pharma A/S Ordinary Share
XNAS•Health Care•Pharmaceutical Preparations
Why is ASND up today? It is at $227.30 (+0.13%), and our scanner flagged it 72 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ASND spikes, and full due diligence on ASND — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ASND 72 times in the last 30 days. Create a free account to track $ASND, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ASND from our scanner (live price and day move above). Fresh from the SEC: Ascendis Pharma A/S filed a Foreign issuer report (6-K). A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystForeign issuer report (6-K), from the latest SEC filing. Read it →Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Bodenhoff Mads Officer | Sold (automatic/other) | -3K | n/a | n/a | $811K at $270.19 | Sep 8, 26 |
Bodenhoff Mads Officer | Other | 3K | n/a | 3K | $330K at $110.00 | Sep 8, 26 |
Holtug Lars Director | Sold (automatic/other) | -236 | sold 5.6% | 4K | $62K at $264.13 | Sep 2, 26 |
Bienaime Jean Jacques Director | Bought (open market) | +2K | added 100% | 3K | $492K at $245.85 | Aug 14, 26 |
Smith Scott Thomas Officer | Bought (open market) | +100 | added 2.3% | 4K | $22K at $219.00 | Jun 2, 26 |
Smith Scott Thomas Officer | Bought (open market) | +250 | added 6.2% | 4K | $56K at $223.32 | May 29, 26 |
Bienaime Jean Jacques Director | Bought (open market) | +500 | added 100% | 900 | $111K at $222.30 | May 29, 26 |
Bienaime Jean Jacques Director | Bought (open market) | +400 | n/a | 400 | $94K at $236.24 | May 26, 26 |
Jensen Flemming Steen Officer | Sold (automatic/other) | -19K 0.03% of company | n/a | n/a | $4.6M at $238.49 | May 11, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ASND from our scanner (live price and day move above). Fresh from the SEC: Ascendis Pharma A/S filed a Foreign issuer report (6-K). A material company disclosure like this is often the real catalyst behind a move of this size.
ASND last traded at $227.30, up 0.13% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Ascendis Pharma A/S Ordinary Share (ASND) is next expected to report earnings on Wednesday, November 11, 2026, about 27 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ASND Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ASND 72 times in the last 30 days.
ASND (Ascendis Pharma A/S Ordinary Share) trades on XNAS, with a market cap of about $14.93B in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ASND for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ASND discussion
Sign in to ask a question or join the discussion.